Immunogen reported $68.46M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 763.03M 47.8M
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Amgen AMGN:US $ 8247M 1087M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Astellas Pharma 4503:JP Y 1382869M 3246M
AstraZeneca AZN:LN 15676M 1246M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Bristol Myers Squibb BMY:US $ 36808M 797M
Cerulean Pharma CERU:US $ 7.74M 4.49M
Dicerna Pharmaceuticals DRNA:US $ 111.07M 15.33M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Emergent Biosolutions EBS:US $ 1543.7M 20.9M
Exelixis EXEL:US $ 2043.08M 131.89M
Halozyme Therapeutics HALO:US $ 119.75M 52.15M
Heron Therapeutics HRTX:US $ 160.11M 36.11M
Immunogen IMGN:US $ 68.46M 25.66M
Intrexon XON:US $ 159.2M 15.6M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Macrogenics MGNX:US $ 319.04M 31.49M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Novartis NVS:US $ 54042M 3519M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Seattle Genetics SGEN:US $ 3391.27M 33.35M